1 Introduction Continuous-flow left ventricular assist devices (LVADs) have become a standard treatment for advanced heart failure, with about 80% of implantations classified as destination therapy [1]. However, these devices induce shear stress on red blood cells (RBCs), which can lead to hemolysis [2]. Hemolysis refers to RBC damage, leading to the release of hemoglobin into plasma, which can occur either through pore formation in the RBC membrane or through complete rupture [2].
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Patrick
Contact Patrick, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack